Yayi He
Clinical trials sponsored by Yayi He, explained in plain language.
-
Promising new cocktail aims to shrink lung tumors
Disease control Not yet recruitingThis study tests a new combination of drugs and radiation as a first treatment for people with limited-stage small cell lung cancer (LS-SCLC) that cannot be removed by surgery. The treatment includes an immunotherapy (benmelstobart), a drug that cuts off tumor blood supply (anlot…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 16, 2026 00:04 UTC
-
New cocktail therapy aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a new treatment plan for people with extensive-stage small cell lung cancer (ES-SCLC) who have not had prior therapy. Participants receive a combination of benmelstobart (an immunotherapy), anlotinib (a targeted drug), and chemotherapy, followed by chest radiatio…
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated May 11, 2026 20:49 UTC